Endpoints News· @endpts · X·· 2026-10-06AI 评分42
AI 导读
Lycia——基于诺贝尔奖得主Carolyn Bertozzi的蛋白质降解科学创立——已递交IPO申请,与此同时TRexBio和Retension也确定了发行条款。
正文
Lycia, built on Nobel laureate Carolyn Bertozzi's protein degradation science, filed for an IPO as TRexBio and Retension set terms. https://endpoints.news/lycia-seeks-ipo-for-antibody-degrader-work-as-trexbio-retension-forge-ahead/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
来源:Endpoints News · x.com